Edaravone: all 36 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment StudyRecruitingNCT07454473Phase 4
• Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic StrokeNot yet recruitingNCT06645522Phase 4
• Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone DexborneolRecruitingNCT06248242Phase 4
• Edaravone in the Treatment of Optic NeuritisRecruitingNCT05540262Not applicable
• Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALSCompletedNCT05568615Phase 3Results posted
• Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)CompletedNCT05342597Phase 1Results posted
• Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric TubeCompletedNCT04776135Phase 1Results posted
• Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult SubjectsCompletedNCT04493281Phase 1Results posted
• Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)CompletedNCT04481789Phase 1Results posted
• Study of Oral Edaravone in Healthy Adult MalesCompletedNCT04481750Phase 1Results posted
• Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With GastrostomyCompletedNCT04254913Phase 1Results posted
• Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral SclerosisCompletedNCT04176224Phase 1Results posted
• A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy SubjectsCompletedNCT04029090Phase 1Results posted
• PK Study in Subjects With Severe Hepatic ImpairmentCompletedNCT03664544Phase 1Results posted
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic ImpairmentCompletedNCT03289234Phase 1Results posted
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal ImpairmentCompletedNCT03289208Phase 1Results posted
• Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral SclerosisCompletedNCT01492686Phase 3Results posted
• Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic StrokeCompletedNCT00821821Phase 2Results posted
• Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00424463Phase 3Results posted
• Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification IIICompletedNCT00415519Phase 3Results posted
• Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00330681Phase 3Results posted
• Pilot Study of Edaravone to Treat Acute Myocardial InfarctionCompletedNCT00265239Phase 4Results posted
• Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic StrokeCompletedNCT00200356Phase 4Results posted
• Bioequivalence of TTYP01 Tablets in Healthy Adult SubjectsCompletedNCT06107205Phase 1
• Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic StrokeStatus unknownNCT05035953Phase 2
• Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time WindowsStatus unknownNCT04817527Phase 2
• Edaravone Dexborneol for Treatment of Hypertensive Intracerebral HemorrhageStatus unknownNCT04714177Phase 2
• Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone DexborneolCompletedNCT04667637Phase 2
• The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALSStatus unknownNCT04391361Phase 2
• Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone InjectionCompletedNCT04218513Phase 1
• Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain InjuryStatus unknownNCT03968042Phase 2
• Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT03272802Phase 2/3
• Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation PatientsStatus unknownNCT02644915Not applicable
• Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic DissectionStatus unknownNCT01894334Not applicable
• Effect of Edaravone on Radiation-induced Temporal Lobe NecrosisCompletedNCT01865201Phase 2
• Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic StrokeCompletedNCT00153946Phase 4

← Edaravone overview